Common Contracts
3 similar Bridge Loan Agreement contracts by Sorrento Therapeutics, Inc., Conduit Pharmaceuticals Inc.
BRIDGE LOAN AGREEMENT Dated as of October 29, 2024Bridge Loan Agreement • November 1st, 2024 • Conduit Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Conduit Pharmaceuticals Inc., a Delaware corporation (the “Borrower”), and A.G.P./Alliance Global Partners (the “Lender”) agree as follows:
BRIDGE LOAN AGREEMENT Dated as of September 30, 2022Bridge Loan Agreement • November 8th, 2022 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Sorrento Therapeutics, Inc., a Delaware corporation (the “Borrower”), and B. Riley Commercial Capital, LLC (the “Lender”) agree as follows:
BRIDGE LOAN AGREEMENT Dated as of February 16, 2022Bridge Loan Agreement • May 5th, 2022 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Sorrento Therapeutics, Inc., a Delaware corporation (the “Borrower”), and B. Riley Commercial Capital, LLC (the “Lender”) agree as follows:
